Inspiring technology for the human brain: ANT’s journey in shaping the future of neurotechnology

Talks

EEG based triage of stroke patients in the ambulance
Dr. Wouter Potters
Done
Sensory processing during sleep and dreams
Prof. Dr. Giulio Bernardi
Done
From SPACE to HEALTH and Back
Prof. Dr. Elsa Kirchner
Done
Transient events in single-trial EEG during photic driving
Hannes Oppermann, MSc
Done
Introduction
Sebastian Carstens
Done
Transcranial magnetic stimulation - mapping, targeting, and computational modeling
Prof. Dr. Thomas R. Knösche
Done
Non-invasive brain stimulation in supporting motor abilities in stroke patients and healthy people
Prof. Dr. Jitka Veldema
Done
EEG in health monitoring for long-term spaceflight
Prof. Patrique Fiedler
Done
Motor reorganization after stroke: From pathophysiology to treatment strategies
Caroline Tscherpel
Done
Assessment of single-trial evoked brain oscillations targeted by transcranial alternating current stimulation using optically-pumped magnetometry
Dr. Vincent Jonany
Done

Location: Room 101 - 11/4/23, 11:45 AM - 11/4/23, 12:15 PM (Europe/Amsterdam) (30 minutes)

Dr. Frank Zanow

Dr. Frank Zanow studied Electrical Engineering at TU Ilmenau (Germany) and received his Ph.D. from the University of Twente (The Netherlands) in 1997 in the field of Applied Physics. Since the establishment of ANT Neuro in 1997, Dr. Zanow successfully led and expanded ANT through skillful management, building a great team focused on the development of innovative hardware and software products. The company now operates globally and provides innovative neuroscience and mental health related solutions, which are in continuous evolution to satisfy an ever-growing market. Between 2014 and 2023, Dr. Zanow was temporarily enrolled as EU researcher at various European universities and remains actively involved in innovation. He is author and co-author of numerous publications related to EEG instrumentation and EEG/MEG applications. To date, Dr. Zanow is the CEO of several entities, which have a strong presence within the global neuroscience and healthcare market.

The presentation will give an overview of ANT Neuro’s journey from a software start-up to a leading medical device manufacturer and the organization’s engagement in various fields of application for non-invasive neurotechnology. The presenter will emphasize the need for continued innovation considering the great potential of EEG as a non-invasive, easy to apply and accessible technology relating to brain health.

Closed-loop applications of transcranial electrical and magnetic stimulation utilize EEG and show promise in the treatment of mental and brain health disorders. The presenter will outline ANT Neuro’s strategy for new technologies such as AI-assisted diagnosis in mental health, highlight collaborative efforts and present first achievements in automated diagnostic screening, prediction and management of brain health conditions.